Our Mission
The Most Comprehensive Study About The U.S. Weight Loss Market--Since 1989
The U.S. Weight Loss & Diet Control Market
May 2017 443 Pages 160 tables/charts Price: $1,895
The $66 billion diet market--analyzed… dollar value & growth rates of the 10 major weight loss market segments (early 1980s to 2016, 2017 and 2022 forecasts), latest market trends and developments, status reports for: diet soft drinks, artificial sweeteners, health clubs, commercial diet center chains, multi-level marketing diet plans, OTC meal replacements and diet pills, diet websites & apps, meal kits delivery services, medical programs (weight loss surgery, MDs, hospitals/clinic programs, Rx diet drugs, bariatricians, VLCD programs), low-cal entrees and low-carb foods, diet books, and exercise DVDs. Also included: 28-year revenues of the market through past recessions, dieter demographics, franchising, and commercial center operating ratios. Rankings & revenues of top commercial chains, brand sales. Contains 35+ in-depth updated competitor profiles. Report also sold by single chapters. Two volumes.
FREE Diet Report
Enter your name and email below and get a FREE 26-page Diet Market Status Report. We'll also keep you informed of any new weight loss market studies.
Latest News
U.S. Weight Loss Market Hits $66 Billion – New Marketdata Report
May 3, 2017 - Marketdata has just released its new biennial report: "The U.S. Weight Loss & Diet Control Market", May 2017 -- a comprehensive 14th edition, 443-page analysis. Price: $1,895. Order at: marketdataenterprises.com (report #FS60), or call Marketdata: 813-971-8080. Some major findings: The total market grew to $66.3 billion in 2016, up from $64.9 billion in 2015. Marketdata analysts Continue Reading
Weight Watchers Reports Strong Q1, Hires New CEO
May 2, 2017 - Management reported that: "In the first quarter, we delivered strong revenue growth and achieved a 16% increase in end of period subscribers versus the prior year period," said Nick Hotchkin, the company's CFO and Member, Interim Office of the CEO. "With a strong start to the year, we are raising our full year 2017 earnings guidance Continue Reading
Medifast Reports Q4 and Full Year 2016 Results
March 9, 2017 - "2016 was a year of strong execution reflecting our continued disciplined approach to effectively managing our business. We grew our revenue for the first time since 2013, increased our profitability year-over-year, and raised our quarterly dividend for 2017, all of which supported a strong return for shareholders in 2016," said Daniel R. Chard, Medifast's CEO. For Q4 Continue Reading
Marketdata weight loss reports have been quoted by...